Peptide Comparison
Syn-Coll vs Tripeptide-29
Editorial breakdown of mechanism, evidence, decision criteria, and the misconceptions worth calling out.
Data-derived verdict
Syn-Coll and Tripeptide-29 share the cosmetic / collagen-stimulator classes and carry roughly equivalent evidence (Cosmetic Clinical Studies / Cosmetic Clinical Studies). The catalogued data does not favor one over the other; pick based on practical fit: route, dosing schedule, cost, regulatory framing, or which specific receptor sub-target matters most for the intended research use.
Evidence at a glance
FDA-approved Phase 3 Phase 2 / approved abroad Anecdotal + animal Preclinical / flagged
Shared safety considerations
Both compounds share these reported concerns: minimal. Open each peptide page for the full risk paragraph and source citations.
Side-by-side
| Syn-Coll | Tripeptide-29 | |
|---|---|---|
| Class | Cosmetic lipopeptide (collagen) | Cosmetic tripeptide (collagen) |
| Drug class | Dermatologic | Dermatologic |
| Mechanism | TSP-1 mimic; activates latent TGF-β; stimulates collagen synthesis | Gly-Pro-Hyp repeat unit; signals fibroblast collagen production |
| Route | Topical | Topical |
| Half-life | Topical | Topical |
| Dosage (research) | Topical 1-5% | Topical 1-5% |
| Evidence tier | Cosmetic Clinical Studies | Cosmetic Clinical Studies |
| Research depth | 12 indexed | 1 indexed |
| Availability | Cosmetic | Cosmetic |
| Reported risks | Minimal | Minimal |
Reported research data only. "Studied for" and "reported in literature" describe published research focus, not clinical recommendation. Most peptides catalogued here are not FDA-approved for human use.
Frequently asked questions
Should I pick Syn-Coll or Tripeptide-29?
Syn-Coll and Tripeptide-29 share the cosmetic / collagen-stimulator classes and carry roughly equivalent evidence (Cosmetic Clinical Studies / Cosmetic Clinical Studies). The catalogued data does not favor one over the other; pick based on practical fit: route, dosing schedule, cost, regulatory framing, or which specific receptor sub-target matters most for the intended research use.
What is the difference between Syn-Coll and Tripeptide-29?
Syn-Coll is classed as Cosmetic lipopeptide (collagen); Tripeptide-29 is classed as Cosmetic tripeptide (collagen). Reported mechanism: Syn-Coll, TSP-1 mimic; activates latent TGF-β; stimulates collagen synthesis; Tripeptide-29, Gly-Pro-Hyp repeat unit; signals fibroblast collagen production. Reported half-life: Syn-Coll, Topical; Tripeptide-29, Topical. Routes in published studies: Syn-Coll, Topical; Tripeptide-29, Topical.
Which has stronger evidence, Syn-Coll or Tripeptide-29?
Syn-Coll and Tripeptide-29 sit on the same rung of PeptideHelper.org's five-step evidence scale, which runs from preclinical to FDA-approved. Syn-Coll is graded Cosmetic Clinical Studies, with 2 cited sources on its reference page and 12 indexed studies. Tripeptide-29 is graded Cosmetic Clinical Studies, with 2 cited sources on its reference page and 1 indexed studies.
Which is more accessible, Syn-Coll or Tripeptide-29?
Neither Syn-Coll nor Tripeptide-29 is an FDA-approved drug. Catalog status: Syn-Coll, Cosmetic; Tripeptide-29, Cosmetic.
Are Syn-Coll and Tripeptide-29 ever combined?
Syn-Coll and Tripeptide-29 appear together in no stack catalogued on PeptideHelper.org, and the interaction engine raises no flag for the pair.
Open the PeptideHelper.org compare tool to add more compounds to this side-by-side and filter by evidence tier interactively.
Loading interactive view…